YOOSAKUL, E.; SEEDUANG, C.; CHUASUWAN, B.; MANAMUTI, C.; PITISUTTITHUM, P.; KARACHOT, B.; TECHATANAWAT, I. Comparative Randomized, Single Dose, Two-Way Crossover, Open-Label Study to Determine the Bioequivalence of Irbesartan Formulation, Irbesartan GPO 150 mg Tablets and Aprovel® 150 mg Tablets, after Oral Administration to Healthy Thai Volunteers under Fasti. Journal of Health Research, [S. l.], v. 30, n. 3, p. 199–205, 2017. Disponível em: https://he01.tci-thaijo.org/index.php/jhealthres/article/view/77939. Acesso em: 8 may. 2024.